top of page
Data on biomarkers utilized in clinical development is woefully missing and not readily available. Arogyam has launched a database of biomarkers supporting precision medicine by curating oncology clinical trials tagged with biomarkers, laboriously classifying, and reshaping the data into a structured format. It covers active trials originating from the US, grouped by therapy class, calls out biomarkers utilized along with their function, trials that use liquid biopsy, single cell, and tumor microenvironment biomarkers. Stay on top of oncology clinical development by therapy class, indications, new & emerging biomarkers of relevance, impact of biomarkers on trial design & outcomes, and the competitive environment.
bottom of page